Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of Alzheimer's disease

Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of Alzheimer's disease

US Patent 11274125 · Granted Mar 15, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating chronic and neuropathic pain mediated by N-type neuronal cal2022
Method for detecting indicators for determining diseases2021
Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosi2021
Method for producing a standard for detecting protein aggregates of a protein mi2021
D-enantiomeric peptides derived from D3 and use thereof2021
Method for treating blood, blood products and organs2020
Method for quantitative characterization of substances with regard to their prop2020
Cyclic, amyloid beta-binding peptides and the use thereof2019
Specific amyloid beta binding peptides and the use of same for treating and diag2019
Specific A-beta species-binding peptides for the therapy and/or diagnosis of Alz2019
D-enantiomeric peptides derived from D3 and use thereof2019
Method for treating blood, blood products and organs2018